Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Editas Medicine, Inc. - Common Stock (NQ:EDIT)

1.045 -0.075 (-6.70%)
Streaming Delayed Price Updated: 10:53 AM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,082,202
Open 1.110
Bid (Size) 1.040 (21)
Ask (Size) 1.050 (49)
Prev. Close 1.120
Today's Range 1.040 - 1.150
52wk Range 1.110 - 7.090
Shares Outstanding 81,632,619
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Future of Healthcare: 10 Predictions For The Next Decade
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we... 
Via MarketMinute
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Editas Medicine Announces Chief Financial Officer Transition
From Editas Medicine, Inc.
Via GlobeNewswire

Performance

YTD
-20.2%
-20.2%
1 Month
-40.6%
-40.6%
3 Month
-20.2%
-20.2%
6 Month
-67.3%
-67.3%
1 Year
-84.8%
-84.8%

More News

Read More
Editas Medicine Stock Slides After-Hours On Bigger-Than-Expected Q4 Loss, But Retail Bulls Eye M&A Potential
Via Stocktwits
Peering Into Editas Medicine's Recent Short Interest
Via Benzinga
12 Analysts Have This To Say About Editas Medicine
Via Benzinga
Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates
From Editas Medicine, Inc.
Via GlobeNewswire
Earnings Scheduled For March 5, 2025
Via Benzinga
Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March
From Editas Medicine, Inc.
Via GlobeNewswire
What's going on in today's session
Via Chartmill
Top movers in Thursday's session
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Top movers analysis one hour before the close of the markets on 2025-02-19: top gainers and losers in today's session.
Via Chartmill
Here are the top movers in Wednesday's session.
Via Chartmill
Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities
From Editas Medicine, Inc.
Via GlobeNewswire
Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Editas Medicine, Inc.
Via GlobeNewswire
JPMorgan Downgrades Editas Medicine, Says Focus Shift Sparks Investor Caution
Via Benzinga
Walmart To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
This Toll Brothers Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Editas Medicine Realigns Strategy to Focus on In Vivo Gene Editing, Targets Human Proof Of Concept By 2026
Via Benzinga
Editas Medicine Announces Strategic Transition to in vivo Gene Editing Company with Intent to Achieve Human Proof of Concept in Approximately Two Years
From Editas Medicine, Inc.
Via GlobeNewswire
Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting
From Editas Medicine, Inc.
Via GlobeNewswire
Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 30
Via Talk Markets
Topics Stocks / Equities
Editas Medicine Downgraded: Analyst Sees Limited Near-Term Catalysts
Via Benzinga
Editas Medicine to Participate in Upcoming Investor Conferences
From Editas Medicine, Inc.
Via GlobeNewswire
Editas Medicine Announces Third Quarter 2024 Results and Business Updates
From Editas Medicine, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Editas Medicine, Inc. - Common Stock publicly traded?
Yes, Editas Medicine, Inc. - Common Stock is publicly traded.
What exchange does Editas Medicine, Inc. - Common Stock trade on?
Editas Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Editas Medicine, Inc. - Common Stock?
The ticker symbol for Editas Medicine, Inc. - Common Stock is EDIT on the Nasdaq Stock Market
What is the current price of Editas Medicine, Inc. - Common Stock?
The current price of Editas Medicine, Inc. - Common Stock is 1.045
When was Editas Medicine, Inc. - Common Stock last traded?
The last trade of Editas Medicine, Inc. - Common Stock was at 04/04/25 10:53 AM ET
What is the market capitalization of Editas Medicine, Inc. - Common Stock?
The market capitalization of Editas Medicine, Inc. - Common Stock is 85.31M
How many shares of Editas Medicine, Inc. - Common Stock are outstanding?
Editas Medicine, Inc. - Common Stock has 85M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.